AHCO AdaptHealth Corp. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
AHCO Stock | Fundamental Analysis & Investment Insights
NASDAQ
Healthcare
Medical Devices
Current Price
Live
$10.65
Analyst Target
$13.38
+25.6%
Upside
52W High
$11.63
52W Low
$7.11
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
AHCO's Piotroski F-Score of 4/9 indicates weak financial health, falling short of the threshold for stability. The absence of an Altman Z-Score raises concern about potential distress risk, especially given a high debt/equity ratio of 1.17 and a current ratio of 1.08. While the stock trades below its Graham Number ($12.4) and intrinsic value ($9.55), its valuation is undermined by deteriorating earnings quality, persistent negative earnings surprises, and a 27.3% YoY EPS decline. Insider selling activity and a technical trend score of 10/100 further signal bearish sentiment. Despite modest revenue growth, profitability remains weak, with low margins and ROE.
Key Strengths
Trading below Graham Number ($12.4), suggesting potential undervaluation on a defensive basis
Price/Sales of 0.44 indicates low valuation relative to revenue
Positive Q/Q EPS growth of 128.6% in most recent quarter suggests short-term recovery momentum
Debt/Equity of 1.17 is below sector average (2.68), indicating relatively moderate leverage
Recent 6-month price return of +15.9% shows some market re-rating despite long-term underperformance
Key Risks
Piotroski F-Score of 4/9 signals weak financial health and declining operational efficiency
Persistent negative earnings surprises over the last 4 quarters (average -42.54%) indicate poor earnings quality
Insider selling of $0.13M in last 6 months with no buys reflects bearish sentiment from insiders
Current ratio of 1.08 and quick ratio of 0.69 suggest tight liquidity and potential short-term solvency concerns
5-year price performance down 70.2% and 3-year down 48.4% reflect deep market skepticism and structural issues
AI Fair Value Estimate
Based on comprehensive analysis
$9.55
-10.3% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare AHCO against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning AHCO from our newsroom.
Newest → oldest
No matching news yet.